Veru Inc PEG
Quel est le PEG de Veru Inc?
Le PEG de Veru Inc est N/A
Quelle est la définition de PEG ?
Le ratio cours / bénéfice sur croissance (PEG) est le ratio P/E d'une action divisé par le taux de croissance de ses bénéfices prévu pour une période de 5 ans.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG des entreprises dans Health Care secteur sur NASDAQ par rapport à Veru Inc
Que fait Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Entreprises avec peg similaire à Veru Inc
- Flexion Therapeutics Inc a PEG de N/A
- Scientific Games a PEG de N/A
- Newpark Resources a PEG de N/A
- C3.ai Inc a PEG de N/A
- Community Health Systems a PEG de N/A
- Covia a PEG de N/A
- Veru Inc a PEG de N/A
- Arcadia Biosciences Inc a PEG de N/A
- Cequence a PEG de N/A
- CPI Card Inc a PEG de N/A
- Evofem Biosciences Inc a PEG de N/A
- Galmed Pharmaceuticals Ltd a PEG de N/A
- Vuzix a PEG de N/A